Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)

NCT04487886 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Duvelisib
DRUG: Placebo

Sponsor

Emory University

Collaborators

[object Object]